NCT04175886View on ClinicalTrials.gov

Effects of Tofacitinib on Body Composition, Bone Mineral Density and Bone Marrow Adiposity in Patients With Rheumatoid Arthritis: the TOFAT Project

TerminatedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

February 25, 2020

Primary Completion Date

May 8, 2023

Study Completion Date

May 8, 2023

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Tofacitinib

Patients will be treated with tofacitinib

Trial Locations (1)

Unknown

Lille University Hospital, Lille

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University Hospital, Lille

OTHER